Salud financiera de hoja de balance de Dr. Reddy's Laboratories
Salud financiera controles de criterios 6/6
Dr. Reddy's Laboratories tiene un patrimonio de accionistas total de ₹309.3B y una deuda total de ₹43.8B, lo que sitúa su ratio deuda-patrimonio en 14.2%. Sus activos y pasivos totales son ₹466.0B y ₹156.7B respectivamente. El BAIT de Dr. Reddy's Laboratories es de ₹67.7B, por lo que su ratio de cobertura de intereses es de -227.8. Tiene efectivo e inversiones a corto plazo que ascienden a ₹63.1B.
Información clave
14.2%
Ratio deuda-patrimonio
₹43.82b
Deuda
| Ratio de cobertura de intereses | -227.8x |
| Efectivo | ₹63.07b |
| Patrimonio | ₹309.28b |
| Total pasivo | ₹156.67b |
| Activos totales | ₹465.96b |
Actualizaciones recientes sobre salud financiera
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14
Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10Recent updates
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?
Nov 23Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Nov 08Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price
Nov 01Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Aug 19Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
Aug 01The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet
Jul 30Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings
Jun 20Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹248.1B) de DRREDDY superan a sus pasivos a corto plazo (₹129.3B).
Pasivo a largo plazo: Los activos a corto plazo de DRREDDY (₹248.1B) superan a sus pasivos a largo plazo (₹27.4B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: DRREDDY tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de DRREDDY ha pasado de 19.3% a 14.2% en los últimos 5 años.
Cobertura de la deuda: La deuda de DRREDDY está bien cubierta por el flujo de caja operativo (77.7%).
Cobertura de intereses: DRREDDY gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.